45 V vs 60 V Pulsed Radiofrequency of the Cervical Dorsal Root Ganglion for Cervical Radicular Pain

July 29, 2026 updated by: Gökhan Yıldız, Ankara Etlik City Hospital

Does Higher Voltage Improve Outcomes in Cervical Radicular Pain? A Comparison of 45 V and 60 V Pulsed Radiofrequency of the Cervical Dorsal Root Ganglion

This study aims to compare the clinical outcomes of 45 V and 60 V pulsed radiofrequency (PRF) applied to the cervical dorsal root ganglion (DRG) in patients with cervical radicular pain. Treatment efficacy will be evaluated using the Numerical Rating Scale (NRS) for pain intensity and the Neck Disability Index (NDI) for functional disability. Procedure-related adverse events will also be compared to assess the safety of both voltage settings.

Study Overview

Detailed Description

Pulsed radiofrequency (PRF) applied to the dorsal root ganglion (DRG) is a well-established minimally invasive treatment for patients with cervical radicular pain who do not respond adequately to conservative management. Although PRF has demonstrated favorable efficacy and safety, the optimal procedural parameters, particularly the applied voltage, remain uncertain. Previous studies have reported conflicting findings regarding the influence of voltage on treatment outcomes, with some suggesting improved long-term pain relief with higher voltages, while others have associated lower voltage settings with better clinical results. More recent evidence has shown favorable outcomes with higher-voltage PRF in cervical radicular pain; however, direct comparisons between commonly used voltage settings, such as 45 V and 60 V, are lacking.

The primary aim of this study is to compare the effectiveness of 45 V and 60 V PRF applied to the cervical DRG in patients with cervical radicular pain using the Numerical Rating Scale (NRS). Secondary aims include comparing functional outcomes using the Neck Disability Index (NDI) and evaluating the safety of both treatment protocols by comparing the incidence of procedure-related adverse events.

Patients who have undergone cervical DRG PRF for cervical radicular pain and completed their treatment will be evaluated according to the voltage applied during the procedure (45 V or 60 V). Pain intensity will be assessed using the Numerical Rating Scale (NRS), and functional disability will be evaluated using the Neck Disability Index (NDI) before treatment and at 3 and 6 months after the procedure. In addition to between-group comparisons, changes from baseline within each group will also be analyzed. Procedure-related adverse events will be recorded throughout the follow-up period.

Study Type

Interventional

Enrollment (Estimated)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Unilateral cervical radicular pain consistent with cervical disc herniation.
  • Pain intensity of ≥6 on the Numerical Rating Scale (NRS).
  • Radicular pain persisting for at least 3 months.
  • MRI evidence of lower cervical nerve root compression consistent with clinical findings.
  • Inadequate response to conservative treatment, including analgesic medications and physical therapy.
  • Completion of cervical dorsal root ganglion pulsed radiofrequency (PRF) treatment.

Exclusion Criteria:

  • Bilateral upper extremity pain or predominant axial neck pain.
  • Cervical spinal stenosis, spondylolisthesis, cervical myelopathy, or other structural spinal disorders causing radicular pain.
  • Previous cervical spine surgery at the target level.
  • Cognitive impairment preventing reliable outcome assessment.
  • Active local or systemic infection.
  • Coagulopathy or inability to discontinue anticoagulant/antiplatelet therapy for the procedure.
  • Severe hepatic or renal failure.
  • Pregnancy.
  • Unstable psychiatric disorders.
  • Any condition that could interfere with completion of follow-up evaluations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 45 V cervical DRG pulsed radiofrequency group
45 V pulsed radiofrequency applied to the cervical dorsal root ganglion for the treatment of cervical radicular pain.
After standard hemodynamic monitoring, the patient was placed in the supine position, and the cervical region was prepared using sterile technique. Under fluoroscopic guidance, the target cervical neural foramen was identified in anteroposterior and lateral views. Following local infiltration with 2 mL of 1% lidocaine, a radiofrequency cannula was advanced to the target cervical dorsal root ganglion. Correct needle placement was confirmed fluoroscopically and by sensory stimulation, which elicited concordant paresthesia in the corresponding dermatome. Pulsed radiofrequency was then applied for 240 seconds at a maximum temperature of 42°C using a voltage of 45 V. After completion of the procedure, the cannula was removed, a sterile dressing was applied, and patients were observed for 60 minutes before discharge.
Active Comparator: 60 V cervical DRG pulsed radiofrequency group
60 V pulsed radiofrequency applied to the cervical dorsal root ganglion for the treatment of cervical radicular pain.
After standard hemodynamic monitoring, the patient was placed in the supine position, and the cervical region was prepared using sterile technique. Under fluoroscopic guidance, the target cervical neural foramen was identified in anteroposterior and lateral views. Following local infiltration with 2 mL of 1% lidocaine, a radiofrequency cannula was advanced to the target cervical dorsal root ganglion. Correct needle placement was confirmed fluoroscopically and by sensory stimulation, which elicited concordant paresthesia in the corresponding dermatome. Pulsed radiofrequency was then applied for 240 seconds at a maximum temperature of 42°C using a voltage of 60 V. After completion of the procedure, the cannula was removed, a sterile dressing was applied, and patients were observed for 60 minutes before discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale (NRS)
Time Frame: Change from baseline to post-treatment at 3 and 6 months.
NRS is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain)
Change from baseline to post-treatment at 3 and 6 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck Disability Index (NDI)
Time Frame: Change from baseline to post-treatment at 3 and 6 months.
NDI is a validated questionnaire used to assess functional disability associated with neck pain. Scores range from 0 to 50, with higher scores indicating greater disability.
Change from baseline to post-treatment at 3 and 6 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gokhan Yildiz, Ankara Etlik City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2026

Primary Completion (Estimated)

February 26, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

July 29, 2026

First Submitted That Met QC Criteria

July 29, 2026

First Posted (Actual)

August 4, 2026

Study Record Updates

Last Update Posted (Actual)

August 4, 2026

Last Update Submitted That Met QC Criteria

July 29, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Cervical DRG PRF 45V vs 60V

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe